Sign In
Last checked at 
19 May 2023 16:15
SMITH & NEPHEW PLC
19 May 2023
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2022 final dividend payment on 17 May 2023. |
Date of Transaction | 2023 - 05 - 17 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) | Director / PDMR | Price | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
Helen Barraclough (Group General Counsel and Company Secretary) | PDMR | £13.13964 | 406.16316 | N/A Single Transaction | 29,139.41087 | 0.00332% |
Bradley Cannon (Global Orthopaedics) | PDMR | £13.13964 | 365.26743 | N/A Single Transaction | 118,184.64237 (including 3,599.09977 in ADS') | 0.01347% |
Paul Connolly (President Global Operations) | PDMR | £13.13964 | 102.08593 | N/A Single Transaction | 7,400.08593 | 0.00084% |
Phil Cowdy (Chief Corporate Development & Corporate Affairs Officer) | PDMR | £13.13964 | 195.14937 | N/A Single Transaction | 49,196.14246 | 0.00561% |
Myra Eskes (President APAC & Global Service) | PDMR | £13.13964 | 855.60779 | N/A Single Transaction | 62,021.97554 | 0.00707% |
Simon Fraser (President AWM and Global Commercial Operations) | PDMR | £13.13964 | 707.85737 | N/A Single Transaction | 51,311.72617 | 0.00585% |
Mizanu Kebede (Chief Quality & Regulatory Affairs Officer) | PDMR | £13.13964 | 54.14835 | N/A Single Transaction | 5,530.80779 (including 802.82972 in ADS') | 0.00063% |
Elga Lohler (Chief HR Officer) | PDMR | £13.13964 | 285.19156 | N/A Single Transaction | 144,683.19156 (including 3,015.00000 in ADS') | 0.01649% |
Deepak Nath (Chief Executive Officer) | Director | £13.13964 | 1,367.8228 | N/A Single Transaction | 99,151.82280 | 0.01130% |
Vasant Padmanabhan (President Research & Development) | PDMR | £13.13964 | 264.13931 | N/A Single Transaction | 100,353.13931 | 0.01143% |
Alison Parkes (Chief Compliance Officer) | PDMR | £13.13964 | 30.61803 | N/A Single Transaction | 4,679.11972 (including 1,040.32795 in ADS') | 0.00053% |
Scott Schaffner (President Sports Medicine) | PDMR | £13.13964 | 763.54875 | N/A Single Transaction | 68,095.98048 (including 1,927.12679 in ADS') | 0.00776% |
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
Follow the stocks
